The death toll in the Democratic Republic of the Congo’s ongoing Ebola outbreak has crossed 5,000, with health officials warning that the crisis shows no sign of slowing.
The Congolese Ministry of Health recorded 5,026 deaths and 10,351 confirmed infections as of the latest data release, producing a case fatality rate approaching 50 percent. The outbreak, first declared in May, has now reached 67 health zones across eight of the country’s 26 provinces, with active transmission still occurring in 50 of those zones.
This marks the second deadliest Ebola outbreak in recorded history, exceeded only by the West Africa epidemic of 2014-2016 that killed approximately 11,000 people over two years. The current crisis is caused by the Bundibugyo virus species, one of four known Ebola variants that can infect humans, for which no approved vaccine or targeted treatment currently exists.
Dr. Patrick Otim, a program manager with the World Health Organization, rejected the idea that the 5,000-death figure should be viewed as a mere statistic.
“The very tragic milestone is just not a number,” he said. “It is families and communities that have been devastated by this outbreak.”
He continued, “The number also shows the severity of this outbreak.”
Medical teams have been managing patients through supportive care based on symptom presentation. That approach has yielded 2,788 recoveries so far, though the high death toll reflects both the virus’s lethality and systemic failures in containment.
The Africa Centers for Disease Control and Prevention disclosed that roughly 80 percent of new infections are appearing outside monitored contact chains, a breakdown that directly undermines standard epidemic response protocols. Contact tracing and rapid testing form the backbone of Ebola containment, and the loss of visibility into transmission networks has allowed the virus to penetrate deep into Congo’s fragmented health system.
Early-stage Bundibugyo infection presents with sudden fever, headache, extreme fatigue, muscle and joint pain, sore throat, appetite loss and chills, according to WHO guidance. Disease progression brings severe diarrhea, persistent vomiting, abdominal pain, nausea, eye redness, skin rash, chest pain, respiratory difficulty and confusion. The most severe cases involve bleeding from mucous membranes, internal hemorrhage, blood in vomit or stool, organ failure and shock.
The geographic spread has been rapid and extensive. From its initial detection point, the outbreak has colonized more than one-third of the country’s health zones, exploiting porous borders between provinces and weak surveillance infrastructure. The May declaration came after health authorities confirmed the Bundibugyo species was circulating in a region already battered by decades of conflict and displacement, factors that have complicated every aspect of the response.